Clinical Trials
228
Active:228
Completed:0
Trial Phases
1 Phases
Phase 1:171
Drug Approvals
12
NMPA:12
Drug Approvals
Fluticasone Propionate Inhalation Aerosol
- Product Name
- 辅舒酮
- Approval Number
- 国药准字HJ20130189
- Approval Date
- Dec 27, 2023
NMPA
Fluticasone Propionate Inhalation Aerosol
- Product Name
- 辅舒酮
- Approval Number
- 国药准字HJ20130190
- Approval Date
- Dec 27, 2023
NMPA
Salbutamol Sulfate Inhalation Aerosol
- Product Name
- 万托林
- Approval Number
- 国药准字HJ20150673
- Approval Date
- Sep 18, 2023
NMPA
Ropinirole Hydrochloride Sustained-release Tablets
- Product Name
- 盐酸罗匹尼罗缓释片
- Approval Number
- 国药准字HJ20150424
- Approval Date
- Aug 10, 2020
NMPA
Ropinirole Hydrochloride Sustained-release Tablets
- Product Name
- 盐酸罗匹尼罗缓释片
- Approval Number
- 国药准字HJ20150415
- Approval Date
- Aug 10, 2020
NMPA
Ropinirole Hydrochloride Sustained-release Tablets
- Product Name
- 盐酸罗匹尼罗缓释片
- Approval Number
- 国药准字HJ20150414
- Approval Date
- Aug 10, 2020
NMPA
Salbutamol Sulfate Inhalation Aerosol
- Product Name
- 万托林
- Approval Number
- H20150673
- Approval Date
- Feb 26, 2019
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (171 trials with phase data)• Click on a phase to view related trials
Phase 1
171 (100.0%)No trials found
News
No news found